Paul Latta
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.8MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 24, 2019 | NIH | SBIR Phase I Targeting a double fail-safe construct to prevent tumorigenesis and select pancreatic endocrine cells from human embryonic stem cells | $224K | Ophysio Inc. |
| Sep 12, 2017 | NIH | SBIR Phase II technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation | $711K | Ophysio Inc. |
| Aug 31, 2017 | NIH | SBIR Phase I Preclinical characterization of THR-123 to induce pancreatic beta cell regeneration (Phase I) | $224K | Ophysio Inc. |
| Sep 2, 2016 | NIH | SBIR Phase II technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation | $732K | Ophysio Inc. |
| Sep 2, 2016 | NIH | SBIR Phase II technologyIn vitro maturation of BMP responsive pancraeatic beta cell progenitors by oxygen modulation | $1.4M | Ophysio Inc. |
| Apr 1, 2015 | NIH | SBIR Phase I In vitro maturation of BMP-7-responsive pancreatic beta cell progenitors by oxygen modulation technology | $225K | Ophysio Inc. |
| Feb 17, 2015 | NIH | SBIR Phase I In vitro maturation of BMP-7-responsive pancreatic beta cell progenitors by oxygen modulation technology | $225K | Ophysio Inc. |
Peer ranks
Federal funding#429
Awards as PI#250
Patents#273
Companies
- Ophysio Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.